Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
osu1272998433.pdf (781.88 KB)
ETD Abstract Container
Abstract Header
Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats
Author Info
Cober, Richard E.
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433
Abstract Details
Year and Degree
2010, Master of Science, Ohio State University, Veterinary Clinical Sciences.
Abstract
Heart rate is one of the main determinants of ischemia, a pathophysiologic characteristic of hypertrophic cardiomyopathy (HCM). Unwanted tachycardia may trigger decompensation in previously asymptomatic cats with HCM. Beta blockers are the primary medications used to reduce heart rate in cats, however, side effects or contraindications sometimes limit their use. Ivabradine is a highly selective If current inhibitor. The drug exerts negative chronotropic effects without significant effects on inotropy, lusitropy, or dromotropy in multiple species. Ivabradine, has never been studied in cats. The purpose of this study was to determine an effective oral dose of ivabradine to significantly reduce heart rate in healthy cats. In this single blinded, placebo controlled, randomized, fully-crossed study 8 healthy cats received placebo or one dose of ivabradine at 0.1 mg/kg, 0.3 mg/kg, or 0.5 mg/kg, PO. HR and blood pressure were monitored continuously for 24 hours via radiotelemetry after each treatment. Response to stress was studied twice by 15-min acoustic startle applied at baseline and 4 hours after drug. Statistical comparisons were made using a linear mixed model and 2-way repeated measures ANOVA. Peak negative chronotropic effect was observed 3 hours after ivabradine administration. Heart rate (min-1) decreased significantly (p<0.05) in a dose-dependent manner (mean±SD for placebo: 144±20; ivabradine 0.1 mg/kg: 133±22; ivabradine 0.3 mg/kg: 112±20; ivabradine 0.5 mg/kg, 104±11). Heart rate (min-1) was still reduced (p<0.05) at 12 hours after ivabradine (0.3 mg/kg: 128±18 and 0.5 mg/kg: 124±16) compared to placebo (141±21). Heart rate response to acoustic startle was significantly (p<0.01) blunted at all 3 doses of ivabradine. No effect of ivabradine on blood pressure was identified and no clinically discernable side effects were observed. These findings indicate that ivabradine at 0.3 mg/kg and 0.5 mg/kg PO predictably lowers HR for at least 12 hours in healthy cats. Clinical studies in cats with HCM are needed.
Committee
Karsten Schober, DVM, PhD (Advisor)
John Bonagura, DVM, MS (Committee Member)
Robert Hamlin, DVM, PhD (Committee Member)
Pages
60 p.
Subject Headings
Animals
;
Veterinary Services
Keywords
Ivabradine
;
Heart Rate
;
Pharmacodynamics
;
If inhibitor
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Cober, R. E. (2010).
Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats
[Master's thesis, Ohio State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433
APA Style (7th edition)
Cober, Richard.
Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats.
2010. Ohio State University, Master's thesis.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433.
MLA Style (8th edition)
Cober, Richard. "Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats." Master's thesis, Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
osu1272998433
Download Count:
1,235
Copyright Info
© 2010, all rights reserved.
This open access ETD is published by The Ohio State University and OhioLINK.